| Biotechnology company Moderna announced Tuesday that its two-shot coronavirus vaccine produced the same immune response in teenagers as adults, and it plans to submit the data to U.S. regulators in early June. If authorized, the vaccine would become the second available for adolescents as young as 12. Pfizer-BioNTech's vaccine was authorized for that age group earlier this month. | 
No comments:
Post a Comment